Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP479932.RAbTqY0GuBz_yCQG2h5mIG4nUIDwCVNDaXIkqH5DZgA7o130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479932.RAbTqY0GuBz_yCQG2h5mIG4nUIDwCVNDaXIkqH5DZgA7o130_provenance.
• NP376521.RA4c3EivIpNHu-CiAAx-MNPqd3HD8iW25oVTXE8WePgiQ130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376521.RA4c3EivIpNHu-CiAAx-MNPqd3HD8iW25oVTXE8WePgiQ130_provenance.
• NP335166.RAtmrjWUCvjhcP12EJidEZrn4oiGXmPWQNKsnmCxnK5Do130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335166.RAtmrjWUCvjhcP12EJidEZrn4oiGXmPWQNKsnmCxnK5Do130_provenance.
• NP423223.RAg5tvu6ltVNXDG9dtuj-o-etIsTtgm6EiEMkpHSERRUY130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423223.RAg5tvu6ltVNXDG9dtuj-o-etIsTtgm6EiEMkpHSERRUY130_provenance.
• NP771467.RASNVLDu-Ctt_BWAuBoNkvbvDB3amoxTTbhiEz9Qammdg130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771467.RASNVLDu-Ctt_BWAuBoNkvbvDB3amoxTTbhiEz9Qammdg130_provenance.
• NP329475.RAMe58_WdFk8NBZHxn3UIzo_23eAqrK4SPNeoaxtDt3mI130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329475.RAMe58_WdFk8NBZHxn3UIzo_23eAqrK4SPNeoaxtDt3mI130_provenance.
• NP565341.RA7yiuzhFFX6hzPM12VN5a8r6uO0o-JAQO8qpeKGtlSVk130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565341.RA7yiuzhFFX6hzPM12VN5a8r6uO0o-JAQO8qpeKGtlSVk130_provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP862393.RA8y2NQPnwAF9WtbuOEb9J9EQnsYRk13sC-xWXj5I3QgQ130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862393.RA8y2NQPnwAF9WtbuOEb9J9EQnsYRk13sC-xWXj5I3QgQ130_provenance.
• NP484080.RAOaFdShheyVjMRgNmI_JNuPmrAFVo-K57iL8dNsESgBY130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484080.RAOaFdShheyVjMRgNmI_JNuPmrAFVo-K57iL8dNsESgBY130_provenance.
• NP470119.RAEEn3X_9oMP_QrsapomLvUDl7zlFH88CQ2RxS8yWVQpY130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470119.RAEEn3X_9oMP_QrsapomLvUDl7zlFH88CQ2RxS8yWVQpY130_provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP718121.RAZSz9lDaQ3yYWF54wJDMf2hTMwtIf35iJIJWyTp91Q2o130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718121.RAZSz9lDaQ3yYWF54wJDMf2hTMwtIf35iJIJWyTp91Q2o130_provenance.
• NP718122.RAYtFEny8PPxKKpgWca4Y2kgwDXGekYmefQvERp050zAY130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718122.RAYtFEny8PPxKKpgWca4Y2kgwDXGekYmefQvERp050zAY130_provenance.
• NP718123.RAczwXc3E2T9LKZXIY94cxumaBHrWS8erwQEQyaNY29HY130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718123.RAczwXc3E2T9LKZXIY94cxumaBHrWS8erwQEQyaNY29HY130_provenance.
• NP718125.RAryejOenzSfQHcv4Qo5THm_oD7qRq_k3h3-pz9h6VLKg130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718125.RAryejOenzSfQHcv4Qo5THm_oD7qRq_k3h3-pz9h6VLKg130_provenance.
• NP718126.RAlOImUfBoctqfzPgnMTVSFYYSaVD7_FzTn5vZo690nE4130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718126.RAlOImUfBoctqfzPgnMTVSFYYSaVD7_FzTn5vZo690nE4130_provenance.
• NP814043.RALjiCTzs5mnOYDoiXCFIGfui8EMZKCgrCY3YqyTl7-EI130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814043.RALjiCTzs5mnOYDoiXCFIGfui8EMZKCgrCY3YqyTl7-EI130_provenance.
• NP882509.RAJ5ELo1Mbm5mS_L3achSFuT45GLmWHhsFk0gNGcwoSFE130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882509.RAJ5ELo1Mbm5mS_L3achSFuT45GLmWHhsFk0gNGcwoSFE130_provenance.
• NP718120.RALuE70DjETIIJZvkiEoV1E7oX1jvOthGIKkS-QOr-Lt4130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718120.RALuE70DjETIIJZvkiEoV1E7oX1jvOthGIKkS-QOr-Lt4130_provenance.
• NP718124.RA4k-arjYkEDSwLUPnuI97Wyvvp2UhY7NCOqj-5lhG7c4130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718124.RA4k-arjYkEDSwLUPnuI97Wyvvp2UhY7NCOqj-5lhG7c4130_provenance.
• NP718127.RA-NrxXrZVlHR0MhrzVLNeqnPWMWzHvTgq8DBzjqjs1JE130_assertion description "[Identifying TAP polymorphisms may potentially be used to identify women less susceptible to progression to high-grade CIN and cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718127.RA-NrxXrZVlHR0MhrzVLNeqnPWMWzHvTgq8DBzjqjs1JE130_provenance.